Psagot Value Holdings’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-12,921
Closed -$247K 451
2019
Q1
$247K Buy
12,921
+1,830
+16% +$35.6K 0.01% 248
2018
Q4
$236K Buy
11,091
+1,985
+22% +$63.2K 0.01% 250
2018
Q3
$415K Hold
9,106
0.02% 187
2018
Q2
$363K Hold
9,106
0.02% 193
2018
Q1
$420K Hold
9,106
0.02% 199
2017
Q4
$417K Hold
9,106
0.02% 184
2017
Q3
$262K Buy
9,106
+939
+11% +$26.3K 0.01% 213
2017
Q2
$247K Hold
8,167
0.01% 206
2017
Q1
$237K Buy
8,167
+3,824
+88% +$146K 0.01% 209
2016
Q4
$205K Buy
4,343
+2,036
+88% +$116K 0.01% 203
2016
Q3
$195K Hold
2,307
0.01% 204
2016
Q2
$198K Buy
2,307
+328
+17% +$34.1K 0.01% 202
2016
Q1
$229K Buy
1,979
+279
+16% +$32.1K 0.01% 235
2015
Q4
$240K Buy
1,700
+416
+32% +$60.9K 0.01% 237
2015
Q3
$183K Buy
1,284
+909
+242% +$252K 0.01% 238
2015
Q2
$123K Buy
+375
New +$120K ﹤0.01% 289

Other funds holding VANI

Psagot Value Holdings's VANI Position: Q2 2019 in Review

Psagot Value Holdings sold out of Vivani Medical (VANI) in Q2 2019, closing a stake of 12,921 shares — an estimated $247K sold.

Psagot Value Holdings first reported a position in VANI in Q2 2015 and held it in 16 quarters. The position peaked at $420K in Q1 2018. 42 funds tracked by Wall St. Rank hold VANI as of Q2 2019.

  • Psagot Value Holdings reported no remaining Vivani Medical position as of Q2 2019 after selling out during the quarter.
  • Psagot Value Holdings sold 12,921 Vivani Medical shares in Q2 2019, an estimated $247K.
  • Psagot Value Holdings first reported a position in Vivani Medical in Q2 2015 and held it in 16 quarters.
  • Psagot Value Holdings's Vivani Medical position peaked at $420K in Q1 2018.
  • 42 funds tracked by Wall St. Rank held Vivani Medical as of Q2 2019.

Based on Psagot Value Holdings's 13F filing for Q2 2019, filed 29 Jul 2019.